Ghostwriters and Guest-writers

Abstract

Get full access to this article

View all access options for this article.

References

Anekwe

. Profits and plagiarism: The case of medical ghostwriting. Bioethics. 2010;24(6):267-272.

Barnett

. Revealed: how drug firms ‘hoodwink’ medical journals. The Observer. Sunday 7 December 2003.

Brennan

. Buying editorials [comment]. New Engl J Med. 1994;331(1):673-675.

Elliott

Landa

. What’s wrong with ghostwriting? Bioethics. 2010;24(6):284-286.

Ghost writing initiated by commercial companies. WAME Policy Statement, June 20, 2005. Available at http://www.wame.org/resources/policies#ghost . Accessed September 13, 2010.

Ghostwriting in Medical Literature. Minority Staff Report, 111th Congress, United States Senate Committee on Finance, June 24, 2010.

Gøtzsche

Hrobjartsson

Johansen

. Ghost authorship in industry-initiated randomised trials. PLOS Med. 2007;4(1):e19. Doi:10.1371/journal.pmed.0040019.

Gøtzsche

Kassirer

Woolley

. What should be done to tackle ghostwriting in the medical literature? PLOS Med. 2009;6(2):e1000023. Doi:10.1371/journal.pmed.1000023.

Graf

Battisti

Bridges

. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ. 2009;339:b4330.

10.

Healy

Cattell

. Interface between authorship, industry and science in the domain of therapeutics. Br J Psychiatr. 2003;183:22-27.

11.

Ngai

Gold

Gill

Rochon

. Haunted manuscripts: Ghost authorship in the medical literature. Accountability in Research. 2005;12:103-114.

12.

Norris

Bowman

Fagan

. International Society for Medical Publication Professionals (ISMPP) position statement: the role of the professional medical writer. Curr Med Res Opin. 2007;23(8):1837-1840.

13.

Shapiro

. Contested Will: Who Wrote Shakespeare? New York: Simon & Schuster, 2010.

14.

Singer

. Report urges more curbs on medical ghostwriting. New York Times. June 24, 2010.

15.

Sismondo

Doucet

. Publication ethics and the ghost management of medical publication. Bioethics. 2010;24(6):273-283.

16.

Steinman

Bero

Chren

Londefeld

. Narrative review: The promotion of gabapentin: An analysis of internal industry documents. Ann Intern Med. 2006;145:284-293.

17.

Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Ethical considerations in the conduct and reporting of research: Authorship and contributorship. Available at http://www.icmje.org/ethical_1author.html . Accessed September 13, 2010.